Akèy › Vezik twò aktif
Etid klinik pou Vezik twò aktif ap rekrite nan Etazini
30 etid pou Vezik twò aktif ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Mountain View, CA6 etid
- Chicago, IL6 etid
- Washington, DC6 etid
- Columbia, SC4 etid
- Cleveland, OH4 etid
- Rochester, MN4 etid
- New York City, NY3 etid
- Arlington, TX3 etid
- Birmingham, AL3 etid
- New Orleans, LA3 etid
- Baltimore, MD3 etid
Pa eta
- Alabama3 etid
- Distrik Columbia4 etid
- Florid4 etid
- Illinois8 etid
- Kalifòni8 etid
- Lwizyàn3 etid
- Maryland5 etid
- Michigan3 etid
- Minnesota6 etid
- Missouri3 etid
- New York4 etid
- North Carolina4 etid
- Ohio4 etid
- South Carolina7 etid
- Texas5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Ambulatory Long Length URodynamics Evaluation
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07425015Aquarius Pilot Study to Evaluate the New Axonics Trial System
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07335484Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 14, 2026 · NCT06511141PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06789406Tensi+ for Treating Overactive Bladder
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07300904Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy
Ap rekrite
Laj 21 ak plis · Fanm · Mizajou Aug 31, 2026 · NCT07662824RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder
Ap rekriteFaz 2
Laj 18 a 80 · Fanm · Mizajou Aug 21, 2026 · NCT07553065Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Aug 19, 2026 · NCT06953271Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Fanm · Mizajou Aug 3, 2026 · NCT07648290Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Ap rekrite
Laj 21 ak plis · Fanm · Mizajou Jul 13, 2026 · NCT07195656BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT04873037Zinc Supplementation With Botulinum Toxin for Overactive Bladder
Ap rekriteFaz 2
Laj 21 a 100 · Fanm · Mizajou Jul 2, 2026 · NCT07405554Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Ap rekriteFaz 2/3
Laj 18 a 89 · Gason · Mizajou Jun 4, 2026 · NCT05878951Add-On ZIDA Sock Therapy for Overactive Bladder
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07432659Noninvasive Ultrasound Assessment of Detrusor Dysfunction
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT05652023Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Mar 23, 2026 · NCT06072703Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Ap rekrite
Laj 18 a 89 · Tout sèks · Mizajou Mar 6, 2026 · NCT04527445TReating Incontinence for Underlying Mental and Physical Health
Ap rekriteFaz 4Volontè an sante akeyi
Laj 60 ak plis · Fanm · Mizajou Mar 6, 2026 · NCT05362292Pelvic Health Electrically Evoked Recording (PEER) 2 Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 3, 2026 · NCT05200923Percutaneous Nerve Evaluation Trial Time
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Fanm · Mizajou Feb 9, 2026 · NCT06226220Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
Ap rekrite
Laj 22 a 80 · Fanm · Mizajou Jan 30, 2026 · NCT07209397A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 28, 2026 · NCT05685433Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT06983470APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Ap rekrite
Laj 22 ak plis · Fanm · Mizajou Oct 27, 2025 · NCT06797245At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Oct 14, 2025 · NCT07178314Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.